United States · FDA National Drug Code directory

Theophylline

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0480-3310_7d1746e6-4ce7-4a14-a2f8-c95bc8941b3c
Product NDC: 0480-3310
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Theophylline
Labeler: Teva Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20230127
Source listing expiry: 20271231

Source-listed ingredients

THEOPHYLLINE — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0480-3310-01) · 0480-3310-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →